Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 5 results found. Search for [ sun pharma halol plant case ]

Results 1 to 5 of 5
PB Jayakumar
New Delhi, December 26, 2019
Sun Pharma's issues with Halol was started in 2015, as the FDA issued a 'warning letter' subsequent to an inspection in September 2014


PB Jayakumar
New Delhi, November 8, 2019
Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in Q2FY20 against Rs 2397 crore in the corresponding quarter of the previous year


PB Jayakumar
New Delhi, June 8, 2018
The inspection team, which inspected the facilities between February 2-23, gave a 'voluntary action indicated' (VAI) remark to Sun's Halol plant in Gujarat.


E. Kumar Sharma
New Delhi, November 25, 2017
Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.


P.B. Jayakumar and E. Kumar Sharma
Delhi, January 16, 2016
Since the past eight months the merged entity has been trading on the Bombay Stock Exchange, nervous investors have been asking two questions - is Shangvi's magic fading? Or, is the slump just a small hitch in Sun's glorious journey over the past one decade?


PAGES 1 OF 1